Drug class in one race
IL-4R-alpha drugs for Atopic Dermatitis
7 tracked IL-4R-alpha drugs in the Atopic Dermatitis race. The class explanation lives on the IL-4R-alpha page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.
1 approved / phase 44 Phase 31 Phase 21 Phase 1
Head-to-head evidence: CKD-706 vs Manfidokimab · CKD-706 vs Rademikibart · CKD-706 vs dupilumab · CKD-706 vs stapokibart · GS101 vs Manfidokimab · GS101 vs Rademikibart